{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:26:27Z","timestamp":1788351987880,"version":"build-2803163510"},"reference-count":133,"publisher":"Elsevier","isbn-type":[{"value":"9780128200025","type":"print"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/bs.pmbts.2020.08.008","type":"book-chapter","created":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T08:38:37Z","timestamp":1599554317000},"page":"297-323","source":"Crossref","is-referenced-by-count":11,"title":["The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pmbts.2020.08.008_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17020189","article-title":"Molecular pathological classification of neurodegenerative diseases: turning towards precision medicine","volume":"17","author":"Kovacs","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0015","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0020","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbadis.2004.06.020","article-title":"Tau protein as a differential biomarker of tauopathies","volume":"1739","author":"Sergeant","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0030","first-page":"1","article-title":"Neuroanatomy and pathology of sporadic Parkinson's disease","volume":"201","author":"Braak","year":"2009","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 Years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.sbi.2008.12.007","article-title":"Prion protein misfolding and disease","volume":"19","author":"Moore","year":"2009","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0045","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/nan.12206","article-title":"Review: prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS)","volume":"41","author":"Smethurst","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0050","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ana.23684","article-title":"Amyotrophic lateral sclerosis and organ donation: is there risk of disease transmission?","volume":"72","author":"Holmes","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0055","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.22615","article-title":"Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders","volume":"70","author":"Jucker","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0060","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/459924a","article-title":"Cell biology: beyond the prion principle","volume":"459","author":"Aguzzi","year":"2009","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0065","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tcb.2015.08.007","article-title":"Cell biology of prions and prionoids: a status report","volume":"26","author":"Aguzzi","year":"2016","journal-title":"Trends Cell Biol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.virusres.2014.12.032","article-title":"From nucleation to widespread propagation: a prion-like concept for ALS","volume":"207","author":"Maniecka","year":"2015","journal-title":"Virus Res"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-neuro-071714-033828","article-title":"Neurodegenerative diseases: expanding the prion concept","volume":"38","author":"Walker","year":"2015","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0080","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-genet-110711-155524","article-title":"Biology and genetics of prions causing neurodegeneration","volume":"47","author":"Prusiner","year":"2013","journal-title":"Annu Rev Genet"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0095","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00401-019-02114-9","article-title":"PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins","volume":"139","author":"Corbett","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01418-5","article-title":"Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments","volume":"440","author":"El-Agnaf","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0110","doi-asserted-by":"crossref","first-page":"19393","DOI":"10.1038\/srep19393","article-title":"Extracellular tau oligomers produce an immediate impairment of LTP and memory","volume":"6","author":"Fa","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0115","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/nn.4648","article-title":"Alpha-synuclein interacts with PrP(C) to induce cognitive impairment through mGluR5 and NMDAR2B","volume":"20","author":"Ferreira","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0120","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1523\/JNEUROSCI.1700-18.2018","article-title":"Cellular prion protein mediates the disruption of hippocampal synaptic plasticity by soluble tau in vivo","volume":"38","author":"Ondrejcak","year":"2018","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0125","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0130","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1523\/JNEUROSCI.1523-15.2015","article-title":"Internalized tau oligomers cause neurodegeneration by inducing accumulation of pathogenic tau in human neurons derived from induced pluripotent stem cells","volume":"35","author":"Usenovic","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0135","first-page":"1","article-title":"A mechanistic hypothesis for the impairment of synaptic plasticity by soluble A\u03b2 oligomers from Alzheimer's brain","author":"Li","year":"2020","journal-title":"J Neurochem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0145","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1074\/jbc.M507892200","article-title":"Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology","volume":"281","author":"Oddo","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0150","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26991","article-title":"LTP and memory impairment caused by extracellular Abeta and Tau oligomers is APP-dependent","volume":"6","author":"Puzzo","year":"2017","journal-title":"Elife"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0155","doi-asserted-by":"crossref","first-page":"11750","DOI":"10.1523\/JNEUROSCI.0234-12.2012","article-title":"Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation","volume":"32","author":"Diogenes","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0160","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/ncomms2534","article-title":"Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia","volume":"4","author":"Kim","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0165","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrneurol.2013.275","article-title":"Extracellular alpha\u2014synuclein-a novel and crucial factor in Lewy body diseases","volume":"10","author":"Lee","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0170","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/brain\/awt375","article-title":"High molecular mass assemblies of amyloid-beta oligomers bind prion protein in patients with Alzheimer's disease","volume":"137","author":"Dohler","year":"2014","journal-title":"Brain"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0175","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1074\/jbc.M112.423954","article-title":"An N-terminal fragment of the prion protein binds to amyloid-beta oligomers and inhibits their neurotoxicity in vivo","volume":"288","author":"Fluharty","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0180","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/ncomms1341","article-title":"Interaction between prion protein and toxic amyloid beta assemblies can be therapeutically targeted at multiple sites","volume":"2","author":"Freir","year":"2011","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0185","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/cbic.201402377","article-title":"Single-molecule imaging reveals that small amyloid-beta1-42 oligomers interact with the cellular prion protein (PrP(C))","volume":"15","author":"Ganzinger","year":"2014","journal-title":"Chembiochem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0190","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers","volume":"457","author":"Lauren","year":"2009","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0195","doi-asserted-by":"crossref","first-page":"15095","DOI":"10.1074\/jbc.M110.199356","article-title":"Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain","volume":"286","author":"Zou","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0200","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1074\/jbc.RA118.006252","article-title":"Systematic and standardized comparison of reported amyloid-beta receptors for sufficiency, affinity, and Alzheimer's disease relevance","volume":"294","author":"Smith","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0205","doi-asserted-by":"crossref","first-page":"26377","DOI":"10.1074\/jbc.M110.145516","article-title":"Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role of N-terminal residues","volume":"285","author":"Chen","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.brainres.2018.12.038","article-title":"PrP-grafted antibodies bind certain amyloid beta-protein aggregates, but do not prevent toxicity","volume":"1710","author":"Mengel","year":"2019","journal-title":"Brain Res"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0215","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/ncomms3416","article-title":"Amyloid-beta nanotubes are associated with prion protein-dependent synaptotoxicity","volume":"4","author":"Nicoll","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0220","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/emboj.2011.86","article-title":"The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication","volume":"30","author":"Resenberger","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0225","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nn.3178","article-title":"Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons","volume":"15","author":"Um","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0230","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/acschemneuro.5b00229","article-title":"Soluble prion protein binds isolated low molecular weight amyloid-beta oligomers causing cytotoxicity inhibition","volume":"6","author":"Williams","year":"2015","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0235","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1096\/fj.12-222588","article-title":"The cellular prion protein traps Alzheimer's Abeta in an oligomeric form and disassembles amyloid fibers","volume":"27","author":"Younan","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0240","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.0911829107","article-title":"Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein","volume":"107","author":"Balducci","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0245","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/emmm.201000082","article-title":"Prion protein and Abeta-related synaptic toxicity impairment","volume":"2","author":"Calella","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0250","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1523\/JNEUROSCI.1459-11.2011","article-title":"Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice","volume":"31","author":"Cisse","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0255","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1038\/nature09217","article-title":"The prion protein as a receptor for amyloid-beta","volume":"466","author":"Kessels","year":"2010","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10236-x","article-title":"Alpha-synuclein amyloids hijack prion protein to gain cell entry, facilitate cell-to-cell spreading and block prion replication","volume":"7","author":"Aulic","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0265","first-page":"1","article-title":"The uptake of tau amyloid fibrils is facilitated by the cellular prion protein and hampers prion propagation in cultured cells","author":"De Cecco","year":"2020","journal-title":"J Neurochem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0270","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.celrep.2018.04.040","article-title":"Extracellular forms of Abeta and tau from iPSC models of Alzheimer's disease disrupt synaptic plasticity","volume":"23","author":"Hu","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0275","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s12035-017-0451-4","article-title":"Involvement of cellular prion protein in alpha-synuclein transport in neurons","volume":"55","author":"Urrea","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0280","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/brain\/awy318","article-title":"Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects","volume":"142","author":"La Vitola","year":"2019","journal-title":"Brain"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0285","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/NEN.0b013e3181e85737","article-title":"A novel PRNP Y218N mutation in Gerstmann-Straussler-Scheinker disease with neurofibrillary degeneration","volume":"69","author":"Alzualde","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0290","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02778006","article-title":"Familial Gerstmann-Straussler-Scheinker disease with neurofibrillary tangles","volume":"8","author":"Ghetti","year":"1994","journal-title":"Mol Neurobiol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0295","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng0492-68","article-title":"Mutant prion proteins in Gerstmann-Straussler-Scheinker disease with neurofibrillary tangles","volume":"1","author":"Hsiao","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0300","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00401-002-0547-3","article-title":"Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Straussler-Scheinker syndrome P102L mutation complicated with dementia","volume":"104","author":"Ishizawa","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0305","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jamaneurol.2013.165","article-title":"Unusual clinical and molecular-pathological profile of Gerstmann-Straussler-Scheinker disease associated with a novel PRNP mutation (V176G)","volume":"70","author":"Simpson","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0310","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jnnp.63.2.240","article-title":"Neurofibrillary tangles in Gerstmann-Straussler-Scheinker syndrome with the A117V prion gene mutation","volume":"63","author":"Tranchant","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0315","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00401-005-1054-0","article-title":"Gerstmann-Straussler-Scheinker disease with the Q217R mutation mimicking frontotemporal dementia","volume":"110","author":"Woulfe","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0320","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s004010051116","article-title":"Variant Gerstmann-Straussler syndrome with the P105L prion gene mutation: an unusual case with nigral degeneration and widespread neurofibrillary tangles","volume":"98","author":"Yamazaki","year":"1999","journal-title":"Acta Neuropathol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0325","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00019052-200406000-00015","article-title":"Recent advances in prion biology","volume":"17","author":"Aguzzi","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0330","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pneurobio.2018.03.001","article-title":"Role of cellular prion protein in interneuronal amyloid transmission","volume":"165\u2013167","author":"Del Rio","year":"2018","journal-title":"Prog Neurobiol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/19336896.2015.1126038","article-title":"Functions of the cellular prion protein, the end of Moore's law, and Ockham's razor theory","volume":"10","author":"del Rio","year":"2016","journal-title":"Prion"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0340","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1152\/physrev.00007.2007","article-title":"Physiology of the prion protein","volume":"88","author":"Linden","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0345","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0092-8674(00)81163-0","article-title":"Prion protein biology","volume":"93","author":"Prusiner","year":"1998","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0350","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(87)90150-4","article-title":"Scrapie prion protein contains a phosphatidylinositol glycolipid","volume":"51","author":"Stahl","year":"1987","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0355","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0306-4522(02)00155-0","article-title":"Selective expression of prion protein in peripheral tissues of the adult mouse","volume":"113","author":"Ford","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3727\/000000003783992324","article-title":"Embryonic activation and developmental expression of the murine prion protein gene","volume":"11","author":"Miele","year":"2003","journal-title":"Gene Expr"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0365","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0890-8508(02)00114-7","article-title":"Tissue-specific expression pattern of bovine prion gene: quantification using real-time RT-PCR","volume":"17","author":"Tichopad","year":"2003","journal-title":"Mol Cell Probes"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0370","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/bs.pmbts.2017.06.002","article-title":"The prion concept and synthetic prions","volume":"150","author":"Legname","year":"2017","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0375","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fnmol.2017.00077","article-title":"The biological function of the prion protein: a cell surface scaffold of signaling modules","volume":"10","author":"Linden","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0380","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1096\/fj.10-161653","article-title":"Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin gamma1 chain","volume":"25","author":"Beraldo","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0385","doi-asserted-by":"crossref","first-page":"36542","DOI":"10.1074\/jbc.M110.157263","article-title":"Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1","volume":"285","author":"Beraldo","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0390","doi-asserted-by":"crossref","first-page":"21857","DOI":"10.1074\/jbc.M116.743435","article-title":"The N terminus of the prion protein mediates functional interactions with the neuronal cell adhesion molecule (NCAM) fibronectin domain","volume":"291","author":"Slapsak","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0395","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1297-1383","article-title":"The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells","volume":"3","author":"Rieger","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0400","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/0092-8674(93)90360-3","article-title":"Mice devoid of PrP are resistant to scrapie","volume":"73","author":"Bueler","year":"1993","journal-title":"Cell"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0405","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/379339a0","article-title":"Normal host prion protein necessary for scrapie-induced neurotoxicity","volume":"379","author":"Brandner","year":"1996","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0410","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.1090187","article-title":"Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis","volume":"302","author":"Mallucci","year":"2003","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0415","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1126\/science.1110837","article-title":"Anchorless prion protein results in infectious amyloid disease without clinical scrapie","volume":"308","author":"Chesebro","year":"2005","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0420","doi-asserted-by":"crossref","first-page":"21223","DOI":"10.1073\/pnas.1117827108","article-title":"Spontaneous generation of anchorless prions in transgenic mice","volume":"108","author":"Stohr","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0425","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/emboj.2008.122","article-title":"Stress-protective signalling of prion protein is corrupted by scrapie prions","volume":"27","author":"Rambold","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0430","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.emboj.7601930","article-title":"The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases","volume":"27","author":"Winklhofer","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0435","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.emboj.7601510","article-title":"Lethal recessive myelin toxicity of prion protein lacking its central domain","volume":"26","author":"Baumann","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0440","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/sj.emboj.7601507","article-title":"Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105\u2013125","volume":"26","author":"Li","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0445","doi-asserted-by":"crossref","first-page":"26719","DOI":"10.1074\/jbc.M110.134619","article-title":"Neurotoxic mutants of the prion protein induce spontaneous ionic currents in cultured cells","volume":"285","author":"Solomon","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0450","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1523\/JNEUROSCI.3406-12.2013","article-title":"A mutant prion protein sensitizes neurons to glutamate-induced excitotoxicity","volume":"33","author":"Biasini","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0455","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23473","article-title":"The N-terminus of the prion protein is a toxic effector regulated by the C-terminus","volume":"6","author":"Wu","year":"2017","journal-title":"Elife"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0460","doi-asserted-by":"crossref","first-page":"21945","DOI":"10.1074\/jbc.M116.738286","article-title":"Regulation of amyloid beta oligomer binding to neurons and neurotoxicity by the prion protein-mGluR5 complex","volume":"291","author":"Beraldo","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0465","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.nbd.2016.03.001","article-title":"Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Abeta oligomers: implications for novel therapeutic strategy in Alzheimer's disease","volume":"91","author":"Scott-McKean","year":"2016","journal-title":"Neurobiol Dis"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0470","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.bbamcr.2017.06.022","article-title":"Diverse functions of the prion protein\u2014does proteolytic processing hold the key?","volume":"1864","author":"Linsenmeier","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0475","doi-asserted-by":"crossref","first-page":"16857","DOI":"10.1523\/JNEUROSCI.1858-12.2012","article-title":"The complex PrP(c)-Fyn couples human oligomeric Abeta with pathological tau changes in Alzheimer's disease","volume":"32","author":"Larson","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0480","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1128\/JVI.75.3.1408-1413.2001","article-title":"Identification of two prion protein regions that modify scrapie incubation time","volume":"75","author":"Supattapone","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0485","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.1523\/JNEUROSCI.1103-12.2012","article-title":"The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc)","volume":"32","author":"Turnbaugh","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0490","first-page":"15","article-title":"Proteolytic processing of the prion protein in health and disease","volume":"1","author":"Altmeppen","year":"2012","journal-title":"Am J Neurodegener Dis"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0495","doi-asserted-by":"crossref","first-page":"19173","DOI":"10.1074\/jbc.270.32.19173","article-title":"Truncated forms of the human prion protein in normal brain and in prion diseases","volume":"270","author":"Chen","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0500","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/glycob\/3.4.319","article-title":"Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor","volume":"3","author":"Borchelt","year":"1993","journal-title":"Glycobiology"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0505","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00018-015-2022-z","article-title":"Prion protein \u201cgamma-cleavage\u201d: characterizing a novel endoproteolytic processing event","volume":"73","author":"Lewis","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0510","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1074\/jbc.M111.323626","article-title":"alpha-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid beta (Abeta)-associated cell death","volume":"287","author":"Guillot-Sestier","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0515","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/jnc.12296","article-title":"Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease","volume":"127","author":"Ostapchenko","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0520","doi-asserted-by":"crossref","first-page":"E782","DOI":"10.1073\/pnas.1714966115","article-title":"Structural heterogeneity and intersubject variability of Abeta in familial and sporadic Alzheimer's disease","volume":"115","author":"Condello","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0525","doi-asserted-by":"crossref","first-page":"13018","DOI":"10.1073\/pnas.1713215114","article-title":"Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease","volume":"114","author":"Rasmussen","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0530","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1586\/ern.11.155","article-title":"Distinguishing Alzheimer's disease from other major forms of dementia","volume":"11","author":"Karantzoulis","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt155","article-title":"Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome","volume":"5","author":"Lam","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0540","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/19336896.2015.1123371","article-title":"Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease","volume":"10","author":"Cohen","year":"2016","journal-title":"Prion"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/v11030261","article-title":"Prion and prion-like protein strains: deciphering the molecular basis of heterogeneity in neurodegeneration","volume":"11","author":"Scialo","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0550","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1523\/JNEUROSCI.0395-10.2010","article-title":"Memory impairment in transgenic Alzheimer mice requires cellular prion protein","volume":"30","author":"Gimbel","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0555","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1038\/nature09218","article-title":"Laur\u00e9n et al. reply","volume":"466","author":"Lauren","year":"2010","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0560","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1074\/jbc.M007243200","article-title":"Cleavage of the amino terminus of the prion protein by reactive oxygen species","volume":"276","author":"McMahon","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0565","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","article-title":"Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein","volume":"79","author":"Um","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0570","doi-asserted-by":"crossref","first-page":"37955","DOI":"10.1074\/jbc.M111.248724","article-title":"Amyloid-beta-induced synapse damage is mediated via cross-linkage of cellular prion proteins","volume":"286","author":"Bate","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0575","doi-asserted-by":"crossref","first-page":"28460","DOI":"10.1074\/jbc.M114.584342","article-title":"Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5)","volume":"289","author":"Haas","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0580","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1038\/ncomms4374","article-title":"mGlu5 receptors and cellular prion protein mediate amyloid-beta-facilitated synaptic long-term depression in vivo","volume":"5","author":"Hu","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0585","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/hmg\/ddr542","article-title":"Cellular prion protein is essential for oligomeric amyloid-beta-induced neuronal cell death","volume":"21","author":"Kudo","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0590","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fncel.2014.00113","article-title":"The role of extracellular Tau in the spreading of neurofibrillary pathology","volume":"8","author":"Medina","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0595","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0173(00)00019-9","article-title":"Tau protein isoforms, phosphorylation and role in neurodegenerative disorders","volume":"33","author":"Buee","year":"2000","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0600","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1021\/bi00158a027","article-title":"Structure and novel exons of the human tau gene","volume":"31","author":"Andreadis","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0605","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/0896-6273(89)90050-0","article-title":"The microtubule binding domain of tau protein","volume":"2","author":"Lee","year":"1989","journal-title":"Neuron"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0610","first-page":"1381","article-title":"Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains","volume":"9","author":"Himmler","year":"1989","journal-title":"Mol Cell Biol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0615","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.11-199851","article-title":"Identification of oligomers at early stages of tau aggregation in Alzheimer's disease","volume":"26","author":"Lasagna-Reeves","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0620","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/156720511796717177","article-title":"Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies","volume":"8","author":"Lasagna-Reeves","year":"2011","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0625","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fncel.2015.00464","article-title":"Tau oligomers: the toxic player at synapses in Alzheimer's disease","volume":"9","author":"Guerrero-Munoz","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0630","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.ajpath.2011.07.044","article-title":"Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease","volume":"179","author":"Vana","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0635","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000353687","article-title":"Prefibrillar tau oligomers in mild cognitive impairment and Alzheimer's disease","volume":"13","author":"Mufson","year":"2014","journal-title":"Neurodegener Dis"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0640","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.nbd.2019.03.022","article-title":"Soluble tau aggregates inhibit synaptic long-term depression and amyloid beta-facilitated LTD in vivo","volume":"127","author":"Ondrejcak","year":"2019","journal-title":"Neurobiol Dis"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0645","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11010-007-9664-6","article-title":"Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro","volume":"310","author":"Wang","year":"2008","journal-title":"Mol Cell Biochem"},{"issue":"suppl 6","key":"10.1016\/bs.pmbts.2020.08.008_bb0650","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/mds.10559","article-title":"Clinical overview of the synucleinopathies","volume":"18","author":"Marti","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0655","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0660","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0665","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah3374","article-title":"Pathological alpha-synuclein transmission initiated by binding lymphocyte-activation gene 3","volume":"353","author":"Mao","year":"2016","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2020.08.008_bb0670","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/19336896.2017.1334748","article-title":"The cellular prion protein (PrP(C)) as neuronal receptor for alpha-synuclein","volume":"11","author":"Urrea","year":"2017","journal-title":"Prion"}],"container-title":["Progress in Molecular Biology and Translational Science","Prions and Neurodegenerative Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187711732030123X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187711732030123X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T04:02:37Z","timestamp":1761796957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187711732030123X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128200025"],"references-count":133,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2020.08.008","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}